$OMDA

Cook Steven L. sold $149K of OMDA

Cook Steven L. (Chief Financial Officer) sold 6,800 shares of Omada Health, Inc. (OMDA) at an average of $21.86 ($21.80–$22.52, $0.15M total) across 2 trades on 2026-09-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cook Steven L.
Published Sep 14, 2026, 9:12 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 14, 2026, 9:37 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$OMDA
Bearish
medium confidence
Mentioned
$OMDA
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDABearishLow
01

Why it matters

The CFO's sale is modest and unlikely to move the stock significantly, but it adds to the flow of insider activity data.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

The CFO's 10b5‑1 plan may have been pre‑scheduled, reducing informational value.

Relevance 3/10Novelty 4/10Timing: post‑market 2026‑09‑10

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$OMDABearishMedium confidence
Context

CFO Steven L. Cook sold 6,800 shares for $148,639.90 on 2026-09-10 via a 10b5‑1 plan.

Expected impact

Potential modest downward pressure on OMDA price.

Evidence & confidence

The sale size is small relative to holdings, but CFO insider sales often weigh on market perception.

Market effects

Minimal impact on digital health sector.

No regional effect beyond OMDA.

Limited to investors tracking insider activity.

Counterpoint

The sale could be routine liquidity planning, not a negative signal.

Key entities

  • Omada Health, Inc.

    Digital health platform listed on Nasdaq under OMDA.

  • Steven L. Cook

    Chief Financial Officer of Omada Health.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$OMDAHighAI 9/10

Omada Health (OMDA) Q2 2026 Earnings Call Transcript

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

$OMDAHigh

Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch